Literature DB >> 20634064

Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.

Esther Vicente1, Pablo R Duchowicz, Diego Benítez, Eduardo A Castro, Hugo Cerecetto, Mercedes González, Antonio Monge.   

Abstract

In a continuing effort to identify new active compounds for combating Chagas disease and other neglected diseases, our research group synthesized and evaluated 23 3-arylquinoxaline-2-carbonitrile di-N-oxides against Trypanosoma cruzi. Five of them presented IC(50) values of the same magnitude as the standard drug Nifurtimox, making them valid as new lead compounds. The optimized molecular structures of 23 derivatives represented by 1497 types of DRAGON descriptors were subjected to linear regression analysis, and the derived QSAR was shown to be predictive. In this way, we achieved a rational guide for the proposal of new candidate structures whose activities still remain unknown. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634064     DOI: 10.1016/j.bmcl.2010.06.101

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  QSAR analysis on tacrine-related acetylcholinesterase inhibitors.

Authors:  Kai Y Wong; Andrew G Mercader; Laura M Saavedra; Bahareh Honarparvar; Gustavo P Romanelli; Pablo R Duchowicz
Journal:  J Biomed Sci       Date:  2014-09-20       Impact factor: 8.410

2.  Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide.

Authors:  Xiulong Shen; Anuruddha Rajapakse; Fabio Gallazzi; Venkatraman Junnotula; Tarra Fuchs-Knotts; Rainer Glaser; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2013-12-19       Impact factor: 3.739

3.  Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.

Authors:  Yunzhen Hu; Qing Xia; Shihao Shangguan; Xiaowen Liu; Yongzhou Hu; Rong Sheng
Journal:  Molecules       Date:  2012-08-13       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.